Cleveland Clinic researchers have found evidence that manipulating the channel activity of TRPV4 may provide a novel therapeutic approach for fibrotic diseases of the lung and other organs.
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy